Sigma Healthcare Ltd (ASX: SIG) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Sigma Pharmaceuticals Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $656.75 million
P/E Ratio 10.67
Dividend Yield 1.59%
Shares Outstanding 1.06 billion
Earnings per share 0.059
Dividend per share 0.01
Year To Date Return 4.07%
Earnings Yield 9.37%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Sigma Healthcare Ltd (ASX: SIG)
Latest News

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
06 Apr 2021 $0.0100 100.00% Final 21 Apr 2021
19 Sep 2019 $0.0100 100.00% Interim 04 Oct 2019
03 Apr 2019 $0.0200 100.00% Final 29 Apr 2019
12 Oct 2018 $0.0150 100.00% Interim 29 Oct 2018
05 Apr 2018 $0.0250 100.00% Final 20 Apr 2018
19 Sep 2017 $0.0250 100.00% Interim 05 Oct 2017
06 Apr 2017 $0.0300 100.00% Final 21 Apr 2017
20 Sep 2016 $0.0250 100.00% Interim 03 Oct 2016
06 Apr 2016 $0.0300 100.00% Final 21 Apr 2016
23 Sep 2015 $0.0200 100.00% 07 Oct 2015
31 Mar 2015 $0.0100 100.00% 16 Apr 2015
31 Mar 2015 $0.0200 100.00% 16 Apr 2015
03 Apr 2014 $0.0200 100.00% Final 30 Apr 2014
21 Sep 2012 $0.0200 100.00% Interim 26 Oct 2012
05 Apr 2011 $0.1500 100.00% Special Cash 11 May 2011
16 Oct 2009 $0.0300 100.00% Interim 13 Nov 2009
31 Mar 2009 $0.0400 100.00% Final 07 May 2009

SIG ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Sigma Healthcare Ltd

Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy and 10% for hospitals. As a result, Sigma and its competitors, EBOS and API, are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.

SIG Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
16 Sep 2021 $0.62 $-0.01 -1.59% 965,002 $0.63 $0.63 $0.62
15 Sep 2021 $0.63 $0.00 0.00% 539,629 $0.63 $0.63 $0.62
14 Sep 2021 $0.63 $0.00 0.00% 968,198 $0.64 $0.64 $0.62
13 Sep 2021 $0.63 $-0.01 -1.56% 989,819 $0.65 $0.65 $0.62
10 Sep 2021 $0.64 $-0.01 -1.54% 562,942 $0.65 $0.65 $0.63
09 Sep 2021 $0.65 $0.00 0.00% 575,712 $0.65 $0.65 $0.64
08 Sep 2021 $0.65 $0.00 0.00% 567,899 $0.65 $0.65 $0.64
07 Sep 2021 $0.65 $0.00 0.00% 223,813 $0.64 $0.65 $0.64
06 Sep 2021 $0.65 $0.01 1.56% 509,210 $0.64 $0.65 $0.63
03 Sep 2021 $0.64 $0.02 3.23% 441,753 $0.63 $0.64 $0.62
02 Sep 2021 $0.62 $0.00 0.00% 439,209 $0.63 $0.63 $0.62
01 Sep 2021 $0.62 $-0.03 -4.65% 970,741 $0.64 $0.64 $0.62
31 Aug 2021 $0.65 $0.01 1.57% 1,013,613 $0.64 $0.66 $0.63
30 Aug 2021 $0.64 $0.02 3.23% 996,712 $0.63 $0.64 $0.62
27 Aug 2021 $0.62 $-0.02 -3.15% 473,487 $0.64 $0.64 $0.62
26 Aug 2021 $0.64 $0.01 1.59% 312,708 $0.64 $0.64 $0.62
25 Aug 2021 $0.63 $-0.01 -1.56% 321,370 $0.64 $0.64 $0.63
24 Aug 2021 $0.64 $0.00 0.00% 664,840 $0.64 $0.65 $0.63
23 Aug 2021 $0.64 $0.02 3.20% 408,048 $0.63 $0.64 $0.63
20 Aug 2021 $0.63 $-0.02 -3.13% 599,962 $0.62 $0.65 $0.62
19 Aug 2021 $0.64 $0.02 3.23% 854,906 $0.63 $0.64 $0.62
18 Aug 2021 $0.62 $-0.01 -1.59% 998,438 $0.63 $0.64 $0.62
17 Aug 2021 $0.63 $0.01 1.60% 595,368 $0.63 $0.64 $0.63

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
06 Jul 2021 Kathryn (Kate) Spargo Buy 8 $5,101
Directors' share plan.
06 Jul 2021 Raymond Gunston Buy 17 $10,607
Directors' share plan.
06 Jul 2021 David Manuel Buy 9 $5,820
Directors' share plan.
06 Jul 2021 Christine Bartlett Buy 9 $5,641
Directors' share plan.
06 Jul 2021 Michael Sammells Buy 9 $6,000
Directors' share plan.
31 Mar 2021 Michael Sammells Buy 8 $6,000
Directors' share plan.
31 Mar 2021 Christine Bartlett Buy 8 $5,641
Directors' share plan.
31 Mar 2021 David Manuel Buy 8 $5,820
Directors' share plan.
31 Mar 2021 Kathryn (Kate) Spargo Buy 7 $5,101
Directors' share plan.
31 Mar 2021 David Bayes Buy 7 $4,922
Directors' share plan.
31 Mar 2021 Raymond Gunston Buy 15 $10,607
Directors' share plan.
31 Mar 2021 Mark Hooper Buy 590 $401,582
Conversion of securities.
31 Mar 2021 Mark Hooper Exercise 590 $401,582
Conversion of securities. 1,402,094 - performance rights
25 Mar 2021 Mark Hooper Cancelled 147 $102,610
Cancellation of securities. 1,992,657 - Performance rights
25 Mar 2021 Mark Hooper Cancelled 8 $5,568,073
Cancellation of securities.
16 Dec 2020 Kathryn (Kate) Spargo Buy 8 $5,282
Directors' share plan.
16 Dec 2020 Raymond Gunston Buy 15 $9,073
Directors' share plan.
16 Dec 2020 David Bayes Buy 8 $4,922
Directors' share plan.
16 Dec 2020 David Manuel Buy 9 $5,581
Directors' share plan.
16 Dec 2020 Christine Bartlett Buy 12 $7,296
Directors' share plan.
16 Dec 2020 Michael Sammells Buy 9 $5,941
Directors' share plan.
27 Oct 2020 Mark Hooper Buy 250 $135,148
On-market trade.
30 Sep 2020 Kathryn (Kate) Spargo Buy 8 $5,102
Directors' share plan.
30 Sep 2020 Mark Hooper Buy 250 $140,127
On-market trade.
30 Sep 2020 David Bayes Buy 8 $4,922
Directors' share plan.
30 Sep 2020 Raymond Gunston Buy 18 $10,607
Directors' share plan.
30 Sep 2020 Michael Sammells Buy 10 $6,000
Directors' share plan.
30 Sep 2020 Christine Bartlett Buy 9 $5,641
Directors' share plan.
30 Sep 2020 David Manuel Buy 10 $5,820
Directors' share plan.
22 Sep 2020 Mark Hooper Buy 500 $294,476
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Mark Robert Hooper Chief Executive OfficerManaging Director Aug 2010
Mr Hooper has a range of experience in finance, commercial and operational matters primarily in the mining and pharmaceutical industries. Mr Hooper is a former Chief Financial Officer and Executive Director of PaperlinX Limited. From 2006 to 2008 Mr Hooper was the Chief Financial Officer and Chief Operating Officer for the Pharmacy and Consumer business for Symbion Health Limited. Prior to that he was Chief Financial Officer of Sigma from 2001 to 2006.
Ms Kathryn (Kate) Dianne Spargo Non-Executive Director Dec 2015
Ms Spargo has gained business experience as both an adviser, having worked in private practice and government, and as a director of listed and unlisted companies. Ms Spargo is currently Non-Executive Director at Sonic Healthcare Limited, Adairs Limited, and CIMIC Ltd. Ms Spargo has held as Non-Executive Director in Xenith IP Ltd and Fletcher Building Limited. In addition, Ms Spargo's current positions in unlisted companies include Chairman of CoInvest and Director at the Geelong Football Club and Future Fuels Cooperative Research Centre. She is a Member of Risk Management Committee.
Mr Raymond Mark Gunston Non-Executive DirectorNon-Executive Chairman Jul 2010
Mr Gunston is a Non-Executive Director and Chairman of the Board of Hotel Property Investments Limited. He has over 40 years of corporate and financial services experience in the public and private sectors, specialising in finance, treasury, mergers and acquisitions, and accounting. He is a former Chief Financial Officer of Tatts Group Limited, and of the Australian Football League, a former Director of many of the Tatts Group's subsidiary and associate companies, and the former Interim CEO for the Essendon AFL Football Club. Mr Gunston is currently Chairman of AFL Stadia Pty. Ltd. (Marvel Stadium).
Mr David Gerald Manuel Non-Executive Director Oct 2009
Mr Manuel has an participant in industry affairs with a special interest in cognitive services such as opiate dependency treatments, compounding, medical technology and aged care pharmacy services. Mr Manuel is a Director of Alchemy Healthcare Pty Ltd, Black Swan Healthcare Ltd, and Elements Health Care Pty Ltd. He is a current Western Australian representative on the Amcal Guardian National Council (AGNC) and a current Branch Committee Member of The Pharmacy Guild of Australia (WA Branch). He is a member of the People and the Risk Management Committee.
Ms Christine Nildra Bartlett Non-Executive Director Mar 2016
Ms Bartlett as an experienced CEO and senior executive has commercial expertise, with a focus in areas of financial discipline, risk management, innovation, technology, and strategy execution. Ms Bartlett's current directorships in listed entities include Non-Executive Director at Mirvac Group and Reliance Worldwide Corporation Ltd. Ms Bartlett resigned as a Director of GBST Ltd in November 2019. She is a Chair of Remuneration Committee.
Mr Michael Sammells Non-Executive Director Feb 2020
Mr Sammells is currently a NonExecutive Director at AMP. Mr Sammells has 35 years of experience in finance, corporate services, and has held operational roles with expertise in finance, accounting, treasury, investor relations, capital developments, mergers and acquisitions and IPOs. Mr Sammells is a former Chief Financial Officer of Healthscope Limited and Medibank Private. He is a Chair of Risk Management Committee.
Mr Peter Robert Patterson Company Secretary Jul 2021
-
J Pearson Chief Financial Officer
-
Peter Robert Patterson Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 216,547,436 20.44%
Citicorp Nominees Pty Limited 185,269,988 17.49%
J P Morgan Nominees Australia Pty Limited 139,637,946 13.18%
Pacific Custodians Pty Limited 56,376,468 5.32%
National Nominees Limited 54,469,536 5.14%
BNP Paribas Nominees Pty Ltd 27,903,771 2.63%
HSBC Custody Nominees (Australia) Limited i 24,763,999 2.34%
Sigma Employee Share Admin P/L 16,555,615 1.56%
Mr Mark Robert Hooper 11,860,636 1.12%
BNP Paribas Noms Pty Ltd 10,504,240 0.99%
Jeffrey Sells 3,602,441 0.34%
BNP Paribas Nominees Pty Ltd Six Sis Ltd 2,777,953 0.26%
Etiam Pty Limited 2,415,594 0.23%
Netwealth Investments Limited 2,090,029 0.20%
Nabru Nominees Pty Limited 1,500,000 0.14%
Mr Peter Urban 1,438,262 0.14%
Brian Charles Cannon & Rosalie Cannon 1,330,500 0.13%
Neweconomy Com Au Nominees Pty Limited 1,215,726 0.11%
Mrs Pamela Ann Royle 1,126,606 0.11%
Leithner & Company Pty Ltd 1,075,000 0.10%

Profile

since

Note